[ { "name": "COVID-19 Information", "cmsId": "ENAS1111", "guidelineId": "GL52", "positionOnHome": 1, "positionOnToc": -1, "tag": [], "abbrName": "Visit our COVID-19 Hub", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6861_1.0.0.0", "children": [] }, { "name": "Diabetes and Population Health", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_2.1.0.0", "children": [] }, { "name": "Care Delivery Systems", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6861_2.2.1.0", "children": [] }, { "name": "Chronic Care Model", "pageName": "ENAS6861_2.2.2.0", "children": [] }, { "name": "Strategies for System-Level Improvement", "pageName": "ENAS6861_2.2.3.0", "children": [] }, { "name": "Care Teams", "pageName": "ENAS6861_2.2.4.0", "children": [] }, { "name": "Telehealth", "pageName": "ENAS6861_2.2.5.0", "children": [] }, { "name": "Behaviors and Well-being", "pageName": "ENAS6861_2.2.6.0", "children": [] }, { "name": "Cost Considerations for Medication-Taking Behaviors", "pageName": "ENAS6861_2.2.7.0", "children": [] }, { "name": "Access to Care and Quality Improvement", "pageName": "ENAS6861_2.2.8.0", "children": [] } ] } ] }, { "name": "Tailoring Treatment for Social Context", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_3.1.0.0", "children": [] }, { "name": "Food Insecurity", "pageName": "ENAS6861_3.2.0.0", "children": [] }, { "name": "Homelessness and Housing Insecurity", "pageName": "ENAS6861_3.3.0.0", "children": [] }, { "name": "Migrant and Seasonal Agricultural Workers", "pageName": "ENAS6861_3.4.0.0", "children": [] }, { "name": "Language Barriers", "pageName": "ENAS6861_3.5.0.0", "children": [] }, { "name": "Health Literacy and Numeracy", "pageName": "ENAS6861_3.6.0.0", "children": [] }, { "name": "Social Capital\/Community Support", "pageName": "ENAS6861_3.7.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6861_4.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#274592", "themeColor": "#313284", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023", "cmsId": "ENAS6861", "guidelineId": "GL89", "positionOnHome": 4, "positionOnToc": 2, "tag": [], "abbrName": "Improving Care and Promoting Health in Populations", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6861_1.0.0.0", "children": [] }, { "name": "Diabetes and Population Health", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_2.1.0.0", "children": [] }, { "name": "Care Delivery Systems", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6861_2.2.1.0", "children": [] }, { "name": "Chronic Care Model", "pageName": "ENAS6861_2.2.2.0", "children": [] }, { "name": "Strategies for System-Level Improvement", "pageName": "ENAS6861_2.2.3.0", "children": [] }, { "name": "Care Teams", "pageName": "ENAS6861_2.2.4.0", "children": [] }, { "name": "Telehealth", "pageName": "ENAS6861_2.2.5.0", "children": [] }, { "name": "Behaviors and Well-being", "pageName": "ENAS6861_2.2.6.0", "children": [] }, { "name": "Cost Considerations for Medication-Taking Behaviors", "pageName": "ENAS6861_2.2.7.0", "children": [] }, { "name": "Access to Care and Quality Improvement", "pageName": "ENAS6861_2.2.8.0", "children": [] } ] } ] }, { "name": "Tailoring Treatment for Social Context", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_3.1.0.0", "children": [] }, { "name": "Food Insecurity", "pageName": "ENAS6861_3.2.0.0", "children": [] }, { "name": "Homelessness and Housing Insecurity", "pageName": "ENAS6861_3.3.0.0", "children": [] }, { "name": "Migrant and Seasonal Agricultural Workers", "pageName": "ENAS6861_3.4.0.0", "children": [] }, { "name": "Language Barriers", "pageName": "ENAS6861_3.5.0.0", "children": [] }, { "name": "Health Literacy and Numeracy", "pageName": "ENAS6861_3.6.0.0", "children": [] }, { "name": "Social Capital\/Community Support", "pageName": "ENAS6861_3.7.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6861_4.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#274592", "themeColor": "#274592", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Cardiovascular Disease and Risk Management", "cmsId": "ENAS6871", "guidelineId": "GL98", "positionOnHome": 13, "positionOnToc": 11, "tag": [], "abbrName": "Cardiovascular Disease", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6871_1.0.0.0", "children": [] }, { "name": "The Risk Calculator", "pageName": "ENAS6871_2.0.0.0", "children": [] }, { "name": "Hypertension\/Blood Pressure Control", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6871_3.1.0.0", "children": [] }, { "name": "Screening and Diagnosis", "pageName": "ENAS6871_3.2.0.0", "children": [] }, { "name": "Treatment Goals", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_3.3.1.0", "children": [] }, { "name": "Randomized Controlled Trials of Intensive Versus Standard Blood Pressure Control", "pageName": "ENAS6871_3.3.2.0", "children": [] }, { "name": "Meta-analyses of Trials", "pageName": "ENAS6871_3.3.3.0", "children": [] }, { "name": "Individualization of Treatment Targets", "pageName": "ENAS6871_3.3.4.0", "children": [] }, { "name": "Pregnancy and Antihypertensive Medications", "pageName": "ENAS6871_3.3.5.0", "children": [] } ] }, { "name": "Treatment Strategies", "pageName": null, "children": [ { "name": "Lifestyle Intervention", "pageName": "ENAS6871_3.4.1.0", "children": [] }, { "name": "Pharmacologic Interventions", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_3.4.2.1", "children": [] }, { "name": "Classes of Antihypertensive Medications", "pageName": "ENAS6871_3.4.2.2", "children": [] }, { "name": "Multiple-Drug Therapy", "pageName": "ENAS6871_3.4.2.3", "children": [] }, { "name": "Bedtime Dosing", "pageName": "ENAS6871_3.4.2.4", "children": [] }, { "name": "Hyperkalemia and Acute Kidney Injury", "pageName": "ENAS6871_3.4.2.5", "children": [] } ] }, { "name": "Resistant Hypertension", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_3.4.3.1", "children": [] } ] } ] } ] }, { "name": "Lipid Management", "pageName": null, "children": [ { "name": "Lifestyle Intervention", "pageName": "ENAS6871_4.1.0.0", "children": [] }, { "name": "Ongoing Therapy and Monitoring With Lipid Panel", "pageName": "ENAS6871_4.2.0.0", "children": [] } ] }, { "name": "Statin Treatment", "pageName": null, "children": [ { "name": "Primary Prevention", "pageName": "ENAS6871_5.1.0.0", "children": [] }, { "name": "Secondary Prevention", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_5.2.1.0", "children": [] }, { "name": "Initiating Statin Therapy Based on Risk", "pageName": "ENAS6871_5.2.2.0", "children": [] }, { "name": "Primary Prevention (People Without ASCVD)", "pageName": "ENAS6871_5.2.3.0", "children": [] }, { "name": "Age <40 Years and\/or Type 1 Diabetes", "pageName": "ENAS6871_5.2.4.0", "children": [] } ] }, { "name": "Combination Therapy for LDL Cholesterol Lowering", "pageName": null, "children": [ { "name": "Statins and Ezetimibe", "pageName": "ENAS6871_5.3.1.0", "children": [] }, { "name": "Statins and PCSK9 Inhibitors", "pageName": "ENAS6871_5.3.2.0", "children": [] }, { "name": "Statins and Bempedoic Acid", "pageName": "ENAS6871_5.3.3.0", "children": [] } ] }, { "name": "Treatment of Other Lipoprotein Fractions or Targets", "pageName": "ENAS6871_5.4.0.0", "children": [] }, { "name": "Other Combination Therapy", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_5.5.1.0", "children": [] }, { "name": "Statin and Fibrate Combination Therapy", "pageName": "ENAS6871_5.5.2.0", "children": [] }, { "name": "Statin and Niacin Combination Therapy", "pageName": "ENAS6871_5.5.3.0", "children": [] } ] }, { "name": "Diabetes Risk With Statin Use", "pageName": "ENAS6871_5.6.0.0", "children": [] }, { "name": "Lipid-Lowering Agents and Cognitive Function", "pageName": "ENAS6871_5.7.0.0", "children": [] } ] }, { "name": "Antiplatelet Agents", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6871_6.1.0.0", "children": [] }, { "name": "Risk Reduction", "pageName": "ENAS6871_6.2.0.0", "children": [] }, { "name": "Aspirin Use in People <50 Years of Age", "pageName": "ENAS6871_6.3.0.0", "children": [] }, { "name": "Aspirin Dosing", "pageName": "ENAS6871_6.4.0.0", "children": [] }, { "name": "Indications for P2Y12 Receptor Antagonist Use", "pageName": "ENAS6871_6.5.0.0", "children": [] }, { "name": "Combination Antiplatelet and Anticoagulation Therapy", "pageName": "ENAS6871_6.6.0.0", "children": [] } ] }, { "name": "Cardiovascular Disease", "pageName": null, "children": [ { "name": "Screening", "pageName": "ENAS6871_7.1.0.0", "children": [] }, { "name": "Treatment", "pageName": "ENAS6871_7.2.0.0", "children": [] }, { "name": "Cardiac Testing", "pageName": "ENAS6871_7.3.0.0", "children": [] }, { "name": "Screening Asymptomatic Patients", "pageName": "ENAS6871_7.4.0.0", "children": [] }, { "name": "Lifestyle and Pharmacologic Interventions", "pageName": "ENAS6871_7.5.0.0", "children": [] }, { "name": "Glucose-Lowering Therapies and Cardiovascular Outcomes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6871_7.6.1.0", "children": [] }, { "name": "SGLT2 Inhibitor Trials", "pageName": "ENAS6871_7.6.2.0", "children": [] }, { "name": "GLP-1 Receptor Agonist Trials", "pageName": "ENAS6871_7.6.3.0", "children": [] }, { "name": "Glucose-Lowering Therapies and Heart Failure", "pageName": "ENAS6871_7.6.4.0", "children": [] }, { "name": "Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease", "pageName": "ENAS6871_7.6.5.0", "children": [] }, { "name": "Clinical Approach", "pageName": "ENAS6871_7.6.6.0", "children": [] } ] } ] }, { "name": "References", "pageName": "ENAS6871_8.0.0.0", "children": [] } ], "toolList": [ { "name": "Hypertension Treatment", "pageName": "interactive_0001792", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 5, "positionInHome": 1, "type": 2 } ], "videoList": [ { "id": "video_icon_23", "name": "Patient Resources", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://www.knowdiabetesbyheart.org/" } } }, { "id": "video_icon_24", "name": "Professional Resources", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://www.knowdiabetesbyheart.org/professional/" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0001792", "video_icon_23", "video_icon_24" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#674683", "themeColor": "#674683", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Chronic Kidney Disease and Risk Management", "cmsId": "ENAS6872", "guidelineId": "GL99", "positionOnHome": 14, "positionOnToc": 12, "tag": [], "abbrName": "Chronic Kidney Disease", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6872_1.0.0.0", "children": [] }, { "name": "Chronic Kidney Disease", "pageName": null, "children": [ { "name": "Screening", "pageName": "ENAS6872_2.1.0.0", "children": [] }, { "name": "Treatment", "pageName": "ENAS6872_2.2.0.0", "children": [] } ] }, { "name": "Epidemiology of Diabetes and Chronic Kidney Disease", "pageName": "ENAS6872_3.0.0.0", "children": [] }, { "name": "Assessment of Albuminuria and Estimated Glomerular Filtration Rate", "pageName": "ENAS6872_4.0.0.0", "children": [] }, { "name": "Diagnosis of Diabetic Kidney Disease", "pageName": "ENAS6872_5.0.0.0", "children": [] }, { "name": "Staging of Chronic Kidney Disease", "pageName": "ENAS6872_6.0.0.0", "children": [] }, { "name": "Acute Kidney Injury", "pageName": "ENAS6872_7.0.0.0", "children": [] }, { "name": "Surveillance", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6872_8.1.0.0", "children": [] }, { "name": "Prevention", "pageName": "ENAS6872_8.2.0.0", "children": [] } ] }, { "name": "Interventions", "pageName": null, "children": [ { "name": "Nutrition", "pageName": "ENAS6872_9.1.0.0", "children": [] }, { "name": "Glycemic Targets", "pageName": "ENAS6872_9.2.0.0", "children": [] }, { "name": "Blood Pressure and Use of RAAS Inhibitors", "pageName": "ENAS6872_9.3.0.0", "children": [] }, { "name": "Direct Renal Effects of GlucoseLowering Medications", "pageName": "ENAS6872_9.4.0.0", "children": [] }, { "name": "Selection of Glucose-Lowering Medications for People With Chronic Kidney Disease", "pageName": "ENAS6872_9.5.0.0", "children": [] }, { "name": "Renal and Cardiovascular Outcomes of Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease", "pageName": "ENAS6872_9.6.0.0", "children": [] } ] }, { "name": "Referral to a Nephrologist", "pageName": "ENAS6872_10.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6872_11.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#623E7B", "themeColor": "#623E7B", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Retinopathy, Neuropathy, and Foot Care", "cmsId": "ENAS6873", "guidelineId": "GL100", "positionOnHome": 15, "positionOnToc": 13, "tag": [], "abbrName": "Retinopathy, Neuropathy, and Foot Care", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6873_1.1.0.0", "children": [] }, { "name": "Diabetic Retinopathy", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6873_2.1.0.0", "children": [] }, { "name": "Screening", "pageName": null, "children": [ { "name": "Recommendation", "pageName": "ENAS6873_2.2.1.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6873_2.2.2.0", "children": [] }, { "name": "Type 1 Diabetes", "pageName": "ENAS6873_2.2.3.0", "children": [] }, { "name": "Type 2 Diabetes", "pageName": "ENAS6873_2.2.4.0", "children": [] }, { "name": "Pregnancy", "pageName": "ENAS6873_2.2.5.0", "children": [] } ] }, { "name": "Treatment", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6873_2.3.1.0", "children": [] }, { "name": "Photocoagulation Surgery", "pageName": "ENAS6873_2.3.2.0", "children": [] }, { "name": "Anti\u2013Vascular Endothelial Growth Factor Treatment", "pageName": "ENAS6873_2.3.3.0", "children": [] }, { "name": "Adjunctive Therapy", "pageName": "ENAS6873_2.3.4.0", "children": [] } ] } ] }, { "name": "Neuropathy", "pageName": null, "children": [ { "name": "Screening", "pageName": "ENAS6873_3.1.0.0", "children": [] }, { "name": "Diagnosis", "pageName": null, "children": [ { "name": "Diabetic Peripheral Neuropathy", "pageName": "ENAS6873_3.2.1.0", "children": [] }, { "name": "Diabetic Autonomic Neuropathy", "pageName": "ENAS6873_3.2.2.0", "children": [] }, { "name": "Cardiovascular Autonomic Neuropathy", "pageName": "ENAS6873_3.2.3.0", "children": [] }, { "name": "Gastrointestinal Neuropathies", "pageName": "ENAS6873_3.2.4.0", "children": [] }, { "name": "Genitourinary Disturbances", "pageName": "ENAS6873_3.2.5.0", "children": [] } ] }, { "name": "Treatment", "pageName": null, "children": [ { "name": "Rec\u00adom\u00admen\u00adda\u00adtions", "pageName": "ENAS6873_3.3.1.0", "children": [] }, { "name": "Glycemic Control", "pageName": "ENAS6873_3.3.2.0", "children": [] }, { "name": "Lipid Control", "pageName": "ENAS6873_3.3.3.0", "children": [] }, { "name": "Blood Pressure Control", "pageName": "ENAS6873_3.3.4.0", "children": [] }, { "name": "Neuropathic Pain", "pageName": "ENAS6873_3.3.5.0", "children": [] }, { "name": "Orthostatic Hypotension", "pageName": "ENAS6873_3.3.6.0", "children": [] }, { "name": "Gastroparesis", "pageName": "ENAS6873_3.3.7.0", "children": [] }, { "name": "Erectile Dysfunction", "pageName": "ENAS6873_3.3.8.0", "children": [] } ] } ] }, { "name": "Foot Care", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6873_4.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6873_4.2.0.0", "children": [] }, { "name": "Evaluation for Loss of Protective Sensation", "pageName": "ENAS6873_4.3.0.0", "children": [] }, { "name": "Evaluation for Peripheral Arterial Disease", "pageName": "ENAS6873_4.4.0.0", "children": [] }, { "name": "Patient Education", "pageName": "ENAS6873_4.5.0.0", "children": [] }, { "name": "Treatment", "pageName": "ENAS6873_4.6.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6873_5.0.0.0", "children": [] } ], "toolList": [ { "name": "Guide to Clinical Eye Care for Patients", "pageName": "interactive_0003084", "hasPdf": false, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 1, "positionInHome": 1, "type": 7 } ], "videoList": [ { "id": "video_icon_25", "name": "Patient Eye Doctor Visit", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://diabetes.org/sites/default/files/2021-03/EyeHealth_Resource_Preparing-for-doc-visit.pdf" } } }, { "id": "video_icon_26", "name": "Common Eye Diseases", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://diabetes.org/sites/default/files/2021-03/EyeHealth_Resource_Common-Diabetic-Eye-Disease.pdf" } } }, { "id": "video_icon_27", "name": "Eye Health FAQs", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://diabetes.org/sites/default/files/2021-03/EyeHealth_Resource_FAQ.pdf" } } }, { "id": "video_icon_28", "name": "Eye CE", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professionaleducation.diabetes.org/Public/Catalog/Main.aspx" } } }, { "id": "video_icon_30", "name": "Focus on Diabetes Pocket Guide", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://diabetes.org/sites/default/files/2022-11/FocusOnDiabetes_PocketGuide_2022.pdf" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0003084", "video_icon_25", "video_icon_26", "video_icon_27", "video_icon_28", "video_icon_30" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#5C3773", "themeColor": "#5C3773", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Older Adults", "cmsId": "ENAS6874", "guidelineId": "GL101", "positionOnHome": 16, "positionOnToc": 14, "tag": [], "abbrName": "Older Adults", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Recommendation and Review", "pageName": "ENAS6874_1.0.0.0", "children": [] }, { "name": "Neurocognitive Function", "pageName": "ENAS6874_2.0.0.0", "children": [] }, { "name": "Hypoglycemia", "pageName": "ENAS6874_3.0.0.0", "children": [] }, { "name": "Treatment Goals", "pageName": null, "children": [ { "name": "Recommendation", "pageName": "ENAS6874_4.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6874_2022120828", "children": [] }, { "name": "Older Adults With Good Functional Status and Without Complications", "pageName": "ENAS6874_4.2.0.0", "children": [] }, { "name": "Patients With Complications and Reduced Functionality", "pageName": "ENAS6874_4.3.0.0", "children": [] }, { "name": "Vulnerable Patients at the End of Life", "pageName": "ENAS6874_4.4.0.0", "children": [] }, { "name": "Beyond Glycemic Management", "pageName": "ENAS6874_4.5.0.0", "children": [] } ] }, { "name": "Lifestyle Management", "pageName": "ENAS6874_5.0.0.0", "children": [] }, { "name": "Pharmacologic Therapy", "pageName": null, "children": [ { "name": "Recommendation", "pageName": "ENAS6874_6.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6874_2022120829", "children": [] }, { "name": "Metformin", "pageName": "ENAS6874_6.2.0.0", "children": [] }, { "name": "Thiazolidinediones", "pageName": "ENAS6874_6.3.0.0", "children": [] }, { "name": "Insulin Secretagogues", "pageName": "ENAS6874_6.4.0.0", "children": [] }, { "name": "Incretin-Based Therapies", "pageName": "ENAS6874_6.5.0.0", "children": [] }, { "name": "Sodium\u2013Glucose Cotransporter 2 Inhibitors", "pageName": "ENAS6874_6.6.0.0", "children": [] }, { "name": "Insulin Therapy", "pageName": "ENAS6874_6.7.0.0", "children": [] }, { "name": "Other Factors to Consider", "pageName": "ENAS6874_6.8.0.0", "children": [] } ] }, { "name": "Special Considerations for Older Adults with Type 1 Diabetes", "pageName": "ENAS6874_7.0.0.0", "children": [] }, { "name": "Treatment in Skilled Nursing Facilities and Nusring Homes", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6874_8.1.0.0", "children": [] }, { "name": "Resources", "pageName": "ENAS6874_8.2.0.0", "children": [] }, { "name": "Nutritional Considerations", "pageName": "ENAS6874_8.3.0.0", "children": [] }, { "name": "Hypoglycemia", "pageName": "ENAS6874_8.4.0.0", "children": [] } ] }, { "name": "End-of-Life Care", "pageName": "ENAS6874_9.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6874_10.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#572F6B", "themeColor": "#572F6B", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Children and Adolescents", "cmsId": "ENAS6875", "guidelineId": "GL102", "positionOnHome": 17, "positionOnToc": 15, "tag": [], "abbrName": "Children and Adolescents", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6875_1.0.0.0", "children": [] }, { "name": "Type 1 Diabetes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6875_2.1.0.0", "children": [] }, { "name": "Diabetes Self-Management Education and Support", "pageName": "ENAS6875_2.2.0.0", "children": [] }, { "name": "Nutrition Therapy", "pageName": "ENAS6875_2.3.0.0", "children": [] }, { "name": "Physical Activity and Exercise", "pageName": "ENAS6875_2.4.0.0", "children": [] }, { "name": "School and Child Care", "pageName": "ENAS6875_2.5.0.0", "children": [] }, { "name": "Psychosocial Care", "pageName": "ENAS6875_2.6.0.0", "children": [] }, { "name": "Glycemic Monitoring, Insulin Delivery, and Targets", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6875_2.7.1.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6875_2.7.2.0", "children": [] } ] }, { "name": "Autoimmune Conditions", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6875_2.8.1.0", "children": [] }, { "name": "Thyroid Disease", "pageName": "ENAS6875_2.8.2.0", "children": [] }, { "name": "Celiac Disease", "pageName": "ENAS6875_2.8.3.0", "children": [] } ] }, { "name": "Management of Cardiovascular Risk Factors", "pageName": null, "children": [ { "name": "Hypertension Screening", "pageName": "ENAS6875_2.9.1.0", "children": [] }, { "name": "Hypertension Treatment", "pageName": "ENAS6875_2.9.2.0", "children": [] }, { "name": "Dyslipidemia Screening", "pageName": "ENAS6875_2.9.3.0", "children": [] }, { "name": "Dyslipidemia Treatment", "pageName": "ENAS6875_2.9.4.0", "children": [] }, { "name": "Pathophysiology", "pageName": "ENAS6875_2.9.5.0", "children": [] }, { "name": "Screening", "pageName": "ENAS6875_2.9.6.0", "children": [] }, { "name": "Treatment", "pageName": "ENAS6875_2.9.7.0", "children": [] }, { "name": "Smoking", "pageName": "ENAS6875_2.9.8.0", "children": [] } ] }, { "name": "Microvascular Complications", "pageName": null, "children": [ { "name": "Nephropathy Screening", "pageName": "ENAS6875_2.10.1.0", "children": [] }, { "name": "Nephropathy Treatment", "pageName": "ENAS6875_2.10.2.0", "children": [] }, { "name": "Retinopathy", "pageName": "ENAS6875_2.10.3.0", "children": [] }, { "name": "Neuropathy", "pageName": "ENAS6875_2.10.4.0", "children": [] } ] } ] }, { "name": "Type 2 Diabetes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6875_3.1.0.0", "children": [] }, { "name": "Screening and Diagnosis", "pageName": "ENAS6875_3.2.0.0", "children": [] }, { "name": "Diagnostic Challenges", "pageName": "ENAS6875_3.3.0.0", "children": [] }, { "name": "Management", "pageName": null, "children": [ { "name": "Lifestyle Management", "pageName": "ENAS6875_3.4.1.0", "children": [] }, { "name": "Glycemic Targets", "pageName": "ENAS6875_3.4.2.0", "children": [] }, { "name": "Pharmacologic Management", "pageName": "ENAS6875_3.4.3.0", "children": [] }, { "name": "Metabolic Surgery", "pageName": "ENAS6875_3.4.4.0", "children": [] } ] }, { "name": "Prevention and Management of Diabetes Complications", "pageName": null, "children": [ { "name": "Hypertension", "pageName": "ENAS6875_3.5.1.0", "children": [] }, { "name": "Nephropathy", "pageName": "ENAS6875_3.5.2.0", "children": [] }, { "name": "Neuropathy", "pageName": "ENAS6875_3.5.3.0", "children": [] }, { "name": "Retinopathy", "pageName": "ENAS6875_3.5.4.0", "children": [] }, { "name": "Nonalcoholic Fatty Liver Disease", "pageName": "ENAS6875_3.5.5.0", "children": [] }, { "name": "Obstructive Sleep Apnea", "pageName": "ENAS6875_3.5.6.0", "children": [] }, { "name": "Polycystic Ovary Syndrome", "pageName": "ENAS6875_3.5.7.0", "children": [] }, { "name": "Cardiovascular Disease", "pageName": "ENAS6875_3.5.8.0", "children": [] }, { "name": "Dyslipidemia", "pageName": "ENAS6875_3.5.9.0", "children": [] }, { "name": "Cardiac Function Testing", "pageName": "ENAS6875_3.5.10.0", "children": [] }, { "name": "Psychosocial Factors", "pageName": "ENAS6875_3.5.11.0", "children": [] } ] } ] }, { "name": "Transition from Pediatric to Adult Care", "pageName": "ENAS6875_4.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6875_5.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#6B326A", "themeColor": "#6B326A", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Management of Diabetes in Pregnancy", "cmsId": "ENAS6876", "guidelineId": "GL103", "positionOnHome": 18, "positionOnToc": 16, "tag": [], "abbrName": "Management of Diabetes in Pregnancy", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6876_1.1.0.0", "children": [] }, { "name": "Diabetes in Pregnancy", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6876_2.1.0.0", "children": [] }, { "name": "Preconception Counseling", "pageName": "ENAS6876_2.2.0.0", "children": [] }, { "name": "Preconception Care", "pageName": "ENAS6876_2.3.0.0", "children": [] } ] }, { "name": "Glycemic Targets in Pregnancy", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6876_3.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6876_3.2.0.0", "children": [] }, { "name": "Insulin Physiology", "pageName": "ENAS6876_3.3.0.0", "children": [] }, { "name": "Glucose Monitoring", "pageName": "ENAS6876_3.4.0.0", "children": [] }, { "name": "A1C in Pregnancy", "pageName": "ENAS6876_3.5.0.0", "children": [] }, { "name": "Continuous Glucose Monitoring in Pregnancy", "pageName": "ENAS6876_3.6.0.0", "children": [] } ] }, { "name": "Management of Gestational Diabetes Mellitus", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6876_4.1.0.0", "children": [] }, { "name": "Medical Nutrition Therapy", "pageName": "ENAS6876_4.2.0.0", "children": [] }, { "name": "Physical Activity", "pageName": "ENAS6876_4.3.0.0", "children": [] }, { "name": "Pharmacologic Therapy", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6876_4.4.1.0", "children": [] }, { "name": "Sulfonylureas", "pageName": "ENAS6876_4.4.2.0", "children": [] }, { "name": "Metformin", "pageName": "ENAS6876_4.4.3.0", "children": [] }, { "name": "Insulin", "pageName": "ENAS6876_4.4.4.0", "children": [] } ] } ] }, { "name": "Management of Preexisting Type 1 Diabetes and Type 2 Diabetes in Pregnancy", "pageName": null, "children": [ { "name": "Insulin Use", "pageName": "ENAS6876_5.1.0.0", "children": [] }, { "name": "Type 1 Diabetes", "pageName": "ENAS6876_5.2.0.0", "children": [] }, { "name": "Type 2 Diabetes", "pageName": "ENAS6876_5.3.0.0", "children": [] } ] }, { "name": "Preeclampsia and Aspirin", "pageName": null, "children": [ { "name": "Insulin Use", "pageName": "ENAS6876_6.1.0.0", "children": [] } ] }, { "name": "Pregnancy and Drug Considerations", "pageName": "ENAS6876_7.0.0.0", "children": [] }, { "name": "Postpartum Care", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6876_8.1.0.0", "children": [] }, { "name": "Gestational Diabetes Mellitus", "pageName": null, "children": [ { "name": "Initial Testing", "pageName": "ENAS6876_8.2.1.0", "children": [] }, { "name": "Postpartum Follow-up", "pageName": "ENAS6876_8.2.2.0", "children": [] }, { "name": "Gestational DiabetesMellitus and Type 2 Diabetes", "pageName": "ENAS6876_8.2.3.0", "children": [] }, { "name": "Preexisting Type 1 and Type 2 Diabetes", "pageName": "ENAS6876_8.2.4.0", "children": [] }, { "name": "Contraception", "pageName": "ENAS6876_8.2.5.0", "children": [] } ] } ] }, { "name": "References", "pageName": "ENAS6876_9.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#7F3569", "themeColor": "#7F3569", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Diabetes Care in the Hospital", "cmsId": "ENAS6877", "guidelineId": "GL104", "positionOnHome": 19, "positionOnToc": 17, "tag": [], "abbrName": "Diabetes Care in the Hospital", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6877_1.0.0.0", "children": [] }, { "name": "Hospital Care Delivery Standards", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6877_2.1.0.0", "children": [] }, { "name": "Considerations on Admission", "pageName": "ENAS6877_2.2.0.0", "children": [] }, { "name": "Diabetes Care Specialists in the Hospital", "pageName": "ENAS6877_2.3.0.0", "children": [] } ] }, { "name": "Glycemic Targets in Hospitalized Adults", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6877_3.1.0.0", "children": [] }, { "name": "Standard De\ufb01nitions of Glucose Abnormalities", "pageName": "ENAS6877_3.2.0.0", "children": [] }, { "name": "Glycemic Targets", "pageName": "ENAS6877_3.3.0.0", "children": [] } ] }, { "name": "Blood Glucose Monitoring", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6877_4.1.0.0", "children": [] }, { "name": "Continuous Glucose Monitoring", "pageName": "ENAS6877_4.2.0.0", "children": [] } ] }, { "name": "Glucose-Lowering Treatment in Hospitalized Patients", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6877_5.1.0.0", "children": [] }, { "name": "Insulin Therapy", "pageName": null, "children": [ { "name": "Critical Care Setting", "pageName": "ENAS6877_5.2.1.0", "children": [] }, { "name": "Noncritical Care Setting", "pageName": "ENAS6877_5.2.2.0", "children": [] }, { "name": "Type 1 Diabetes", "pageName": "ENAS6877_5.2.3.0", "children": [] }, { "name": "Transitioning From Intravenous to Subcutaneous Insulin", "pageName": "ENAS6877_5.2.4.0", "children": [] } ] }, { "name": "Noninsulin Therapies", "pageName": "ENAS6877_5.3.0.0", "children": [] } ] }, { "name": "Hypoglycemia", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6877_6.1.0.0", "children": [] }, { "name": "Triggering Events and Prevention of Hypoglycemia", "pageName": "ENAS6877_6.2.0.0", "children": [] }, { "name": "Predictors of Hypoglycemia", "pageName": "ENAS6877_6.3.0.0", "children": [] } ] }, { "name": "Medical Nutrition Therapy in the Hospital", "pageName": "ENAS6877_7.0.0.0", "children": [] }, { "name": "Self-Management in the Hospital", "pageName": "ENAS6877_8.0.0.0", "children": [] }, { "name": "Standards for Special Situations", "pageName": null, "children": [ { "name": "Enteral\/Parenteral Feedings", "pageName": "ENAS6877_9.1.0.0", "children": [] }, { "name": "Glucocorticoid Therapy", "pageName": "ENAS6877_9.2.0.0", "children": [] }, { "name": "Perioperative Care", "pageName": "ENAS6877_9.3.0.0", "children": [] }, { "name": "Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State", "pageName": "ENAS6877_9.4.0.0", "children": [] } ] }, { "name": "Transition from the Hospital to the Ambulatory Setting", "pageName": null, "children": [ { "name": "Recommendation and Overview", "pageName": "ENAS6877_10.1.0.0", "children": [] }, { "name": "Medication Reconciliation", "pageName": "ENAS6877_10.2.0.0", "children": [] }, { "name": "Structured Discharge Communication", "pageName": "ENAS6877_10.3.0.0", "children": [] } ] }, { "name": "Preventing Admissions and Readmissions", "pageName": "ENAS6877_11.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6877_12.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#923867", "themeColor": "#923867", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Diabetes and Advocacy", "cmsId": "ENAS6878", "guidelineId": "GL105", "positionOnHome": 20, "positionOnToc": 18, "tag": [], "abbrName": "Diabetes and Advocacy", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6878_1.0.0.0", "children": [] }, { "name": "Advocacy Statements", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6878_2.1.0.0", "children": [] }, { "name": "Insulin Access and Affordability", "pageName": "ENAS6878_2.2.0.0", "children": [] }, { "name": "Diabetes Care in the School Setting", "pageName": "ENAS6878_2.3.0.0", "children": [] }, { "name": "Care of Young Children With Diabetes in the Childcare Setting", "pageName": "ENAS6878_2.4.0.0", "children": [] }, { "name": "Diabetes and Driving", "pageName": "ENAS6878_2.5.0.0", "children": [] }, { "name": "Diabetes and Employment", "pageName": "ENAS6878_2.6.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6878_3.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#A63B66", "themeColor": "#A63B66", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Classification and Diagnosis of Diabetes", "cmsId": "ENAS6863", "guidelineId": "GL90", "positionOnHome": 5, "positionOnToc": 3, "tag": [], "abbrName": "Classification and Diagnosis of Diabetes", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6863_1.1.0.0", "children": [] }, { "name": "Classification", "pageName": "ENAS6863_1.2.0.0", "children": [] } ] }, { "name": "Diagnostic Tests For Diabetes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6863_2.1.0.0", "children": [] }, { "name": "Fasting and 2-Hour Plasma Glucose", "pageName": "ENAS6863_2.2.0.0", "children": [] }, { "name": "A1C", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6863_2.3.1.0", "children": [] }, { "name": "Age", "pageName": "ENAS6863_2.3.2.0", "children": [] }, { "name": "Race\/Ethnicity\/Hemoglobinopathies", "pageName": "ENAS6863_2.3.3.0", "children": [] }, { "name": "Other Conditions Altering the Relationship of A1C and Glycemia", "pageName": "ENAS6863_2.3.4.0", "children": [] } ] }, { "name": "Confirming the Diagnosis", "pageName": "ENAS6863_2.4.0.0", "children": [] }, { "name": "Diagnosis", "pageName": "ENAS6863_2.5.0.0", "children": [] } ] }, { "name": "Type 1 Diabetes", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6863_3.1.0.0", "children": [] }, { "name": "Immune-Mediated Diabetes", "pageName": "ENAS6863_3.2.0.0", "children": [] }, { "name": "Idiopathic Type 1 Diabetes", "pageName": "ENAS6863_3.3.0.0", "children": [] }, { "name": "Screening for Type 1 Diabetes Risk", "pageName": "ENAS6863_3.4.0.0", "children": [] } ] }, { "name": "Prediabetes And Type 2 Diabetes", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6863_4.1.0.0", "children": [] }, { "name": "Prediabetes", "pageName": "ENAS6863_4.2.0.0", "children": [] }, { "name": "Type 2 Diabetes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6863_4.3.1.0", "children": [] }, { "name": "ADA risk test", "pageName": "ENAS6863_4.3.2.0", "children": [] }, { "name": "Screening and Testing for Prediabetes and Type 2 Diabetes in Asymptomatic Adults", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6863_4.3.3.1", "children": [] }, { "name": "Age", "pageName": "ENAS6863_4.3.3.2", "children": [] }, { "name": "BMI and Ethnicity", "pageName": "ENAS6863_4.3.3.3", "children": [] }, { "name": "Medications", "pageName": "ENAS6863_4.3.3.4", "children": [] }, { "name": "HIV", "pageName": "ENAS6863_4.3.3.5", "children": [] }, { "name": "Testing Interval", "pageName": "ENAS6863_4.3.3.6", "children": [] }, { "name": "Community Screening", "pageName": "ENAS6863_4.3.3.7", "children": [] }, { "name": "Screening in Dental Practices", "pageName": "ENAS6863_4.3.3.8", "children": [] } ] }, { "name": "Screening and Testing for Prediabetes and Type 2 Diabetes in Children and Adolescents", "pageName": "ENAS6863_4.3.4.0", "children": [] } ] } ] }, { "name": "Cystic Fibrosis-Related Diabetes", "pageName": "ENAS6863_5.0.0.0", "children": [] }, { "name": "Posttransplantation Diabetes Mellitus", "pageName": "ENAS6863_6.0.0.0", "children": [] }, { "name": "Monogenic Diabetes Syndromes", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6863_7.1.0.0", "children": [] }, { "name": "Neonatal Diabetes", "pageName": "ENAS6863_7.2.0.0", "children": [] }, { "name": "Maturity-Onset Diabetes of the Young", "pageName": "ENAS6863_7.3.0.0", "children": [] }, { "name": "Diagnosis of Monogenic Diabetes", "pageName": "ENAS6863_7.4.0.0", "children": [] } ] }, { "name": "Pancreatic Diabetes Or Diabetes In The Context Of Disease Of The Exocrine Pancreas", "pageName": "ENAS6863_8.0.0.0", "children": [] }, { "name": "Gestational Diabetes Mellitus", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6863_9.1.0.0", "children": [] }, { "name": "De\ufb01nition", "pageName": "ENAS6863_9.2.0.0", "children": [] }, { "name": "Diagnosis", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6863_9.3.1.0", "children": [] }, { "name": "One-Step Strategy", "pageName": "ENAS6863_9.3.2.0", "children": [] }, { "name": "Two-Step Strategy", "pageName": "ENAS6863_9.3.3.0", "children": [] } ] } ] }, { "name": "References", "pageName": "ENAS6863_10.0.0.0", "children": [] } ], "toolList": [ { "name": "Diabetes Testing in Asymptomatic Adults", "pageName": "interactive_0001780", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 8, "positionInHome": 1, "type": 2 }, { "name": "Diagnosis of Diabetes and Prediabetes", "pageName": "interactive_0001691", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_2", "positionInToc": 9, "positionInHome": 2, "type": 1 } ], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0001780", "interactive_0001691" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#1D589F", "themeColor": "#1D589F", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Prevention or Delay of Type 2 Diabetes and Associated Comorbidities", "cmsId": "ENAS6864", "guidelineId": "GL91", "positionOnHome": 6, "positionOnToc": 4, "tag": [], "abbrName": "Prevention or Delay of Type 2 Diabetes", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6864_1.0.0.0", "children": [] }, { "name": "Lifestyle Behavior Change for Diabetes Prevention", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6864_2.1.0.0", "children": [] }, { "name": "The Diabetes Prevention Program", "pageName": "ENAS6864_2.2.0.0", "children": [] }, { "name": "Nutrition", "pageName": "ENAS6864_2.3.0.0", "children": [] }, { "name": "Physical Activity", "pageName": "ENAS6864_2.4.0.0", "children": [] }, { "name": "Delivery and Dissemination of Lifestyle Behavior Change for Diabetes Prevention", "pageName": "ENAS6864_2.5.0.0", "children": [] } ] }, { "name": "Pharmacologic Interventions", "pageName": "ENAS6864_3.0.0.0", "children": [] }, { "name": "Prevention of Vascular Disease and Mortality", "pageName": "ENAS6864_4.0.0.0", "children": [] }, { "name": "Person-centered Care Goals", "pageName": "ENAS6864_5.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6864_6.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#146CAD", "themeColor": "#146CAD", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Comprehensive Medical Evaluation and Assessment of Comorbidities", "cmsId": "ENAS6865", "guidelineId": "GL92", "positionOnHome": 7, "positionOnToc": 5, "tag": [], "abbrName": "Comprehensive Medical Evaluation and Assessment of Comorbidities", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6865_1.0.0.0", "children": [] }, { "name": "Person Centered Collaborative Care", "pageName": "ENAS6865_2.0.0.0", "children": [] }, { "name": "Comprehensive Medical Evaluation", "pageName": "ENAS6865_3.0.0.0", "children": [] }, { "name": "Immunizations", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6865_4.1.0.0", "children": [] }, { "name": "Influenza", "pageName": "ENAS6865_4.2.0.0", "children": [] }, { "name": "Pneumococcal Pneumonia", "pageName": "ENAS6865_4.3.0.0", "children": [] }, { "name": "Hepatitis B", "pageName": "ENAS6865_4.4.0.0", "children": [] } ] }, { "name": "Covid-19", "pageName": "ENAS6865_5.0.0.0", "children": [] }, { "name": "Assessment of Comorbidities", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6865_6.1.0.0", "children": [] }, { "name": "Autoimmune Diseases", "pageName": "ENAS6865_6.2.0.0", "children": [] }, { "name": "Cancer", "pageName": "ENAS6865_6.3.0.0", "children": [] }, { "name": "Cognitive Impairment\/Dementia", "pageName": null, "children": [ { "name": "Recommendation and Overview", "pageName": "ENAS6865_6.4.1.0", "children": [] }, { "name": "Hyperglycemia", "pageName": "ENAS6865_6.4.2.0", "children": [] }, { "name": "Hypoglycemia", "pageName": "ENAS6865_6.4.3.0", "children": [] }, { "name": "Nutrition", "pageName": "ENAS6865_6.4.4.0", "children": [] }, { "name": "Statins", "pageName": "ENAS6865_6.4.5.0", "children": [] } ] }, { "name": "Nonalcoholic Fatty Liver Disease", "pageName": null, "children": [ { "name": "Recommendation", "pageName": "ENAS6865_6.5.1.0", "children": [] }, { "name": "Screening", "pageName": "ENAS6865_6.5.2.0", "children": [] }, { "name": "Management", "pageName": "ENAS6865_6.5.3.0", "children": [] }, { "name": "Obstructive Sleep Apnea", "pageName": "ENAS6865_2022120627", "children": [] }, { "name": "Periodontal Disease", "pageName": "ENAS6865_6.5.4.0", "children": [] } ] } ] }, { "name": "Diabetes and Covid-19", "pageName": "ENAS6865_7.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6865_8.0.0.0", "children": [] } ], "toolList": [ { "name": "Decision Cycle for Glycemic Mgmt. in T2DM", "pageName": "interactive_0002030", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 7, "positionInHome": 1, "type": 2 } ], "videoList": [ { "id": "video_icon_1", "name": "Critical Conversations Framework", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://therapeuticinertia.diabetes.org/sites/therapeuticinertia.diabetes.org/files/2021-06/critical_conversations_fact_sheet_and_framework_v1.pdf" } } }, { "id": "video_icon_2", "name": "Patient Assessment", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada_patientasessment_final-2021-03-17_0.pdf" } } }, { "id": "video_icon_3", "name": "Patient Care Plan", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/your_diabetescareandmanagementplan_final_11_04_2020.pdf" } } }, { "id": "video_icon_29", "name": "OTI CE", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professionaleducation.diabetes.org/Public/Catalog/Main.aspx" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0002030", "video_icon_1", "video_icon_2", "video_icon_3" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#0A7FBA", "themeColor": "#0A7FBA", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes", "cmsId": "ENAS6866", "guidelineId": "GL93", "positionOnHome": 8, "positionOnToc": 6, "tag": [], "abbrName": "Facilitating Behavior Change", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6866_1.0.0.0", "children": [] }, { "name": "Diabetes Self-Management Education and Support", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6866_2.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6866_2.2.0.0", "children": [] }, { "name": "Evidence for the Benefits", "pageName": "ENAS6866_2.3.0.0", "children": [] }, { "name": "Reimbursement", "pageName": "ENAS6866_2.4.0.0", "children": [] } ] }, { "name": "Medical Nutrition Therapy", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6866_3.1.0.0", "children": [] }, { "name": "Weight Management", "pageName": "ENAS6866_3.2.0.0", "children": [] }, { "name": "Eating Patterns and Meal Planning", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6866_3.3.1.0", "children": [] }, { "name": "Carbohydrates", "pageName": "ENAS6866_3.3.2.0", "children": [] }, { "name": "Protein", "pageName": "ENAS6866_3.3.3.0", "children": [] }, { "name": "Fats", "pageName": "ENAS6866_3.3.4.0", "children": [] }, { "name": "Sodium", "pageName": "ENAS6866_3.3.5.0", "children": [] }, { "name": "Micronutrients and Supplements", "pageName": "ENAS6866_3.3.6.0", "children": [] }, { "name": "Alcohol", "pageName": "ENAS6866_3.3.7.0", "children": [] }, { "name": "Nonnutritive Sweeteners", "pageName": "ENAS6866_3.3.8.0", "children": [] } ] } ] }, { "name": "Physical Activity", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6866_4.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6866_4.2.0.0", "children": [] }, { "name": "Exercise and Children", "pageName": "ENAS6866_4.3.0.0", "children": [] }, { "name": "Frequency and Type of Physical Activity", "pageName": "ENAS6866_4.4.0.0", "children": [] }, { "name": "Physical Activity and Glycemic Management", "pageName": "ENAS6866_4.5.0.0", "children": [] }, { "name": "Pre-exercise Evaluation", "pageName": "ENAS6866_4.6.0.0", "children": [] }, { "name": "Hypoglycemia", "pageName": "ENAS6866_4.7.0.0", "children": [] }, { "name": "Exercise in the Presence of Microvascular Complications", "pageName": null, "children": [ { "name": "Retinopathy", "pageName": "ENAS6866_4.8.1.0", "children": [] }, { "name": "Peripheral Neuropathy", "pageName": "ENAS6866_4.8.2.0", "children": [] }, { "name": "Autonomic Neuropathy", "pageName": "ENAS6866_4.8.3.0", "children": [] }, { "name": "Diabetic Kidney Disease", "pageName": "ENAS6866_4.8.4.0", "children": [] } ] } ] }, { "name": "Smoking Cessation: Tobacco and E-Cigarettes", "pageName": "ENAS6866_5.0.0.0", "children": [] }, { "name": "Supporting Positive Health Behaviors", "pageName": "ENAS6866_6.0.0.0", "children": [] }, { "name": "Psychosocial Care", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6866_7.1.0.0", "children": [] }, { "name": "Screening", "pageName": "ENAS6866_7.2.0.0", "children": [] }, { "name": "Psychological Assessment and Treatment", "pageName": "ENAS6866_7.3.0.0", "children": [] }, { "name": "Diabetes Distress", "pageName": "ENAS6866_7.4.0.0", "children": [] }, { "name": "Anxiety", "pageName": "ENAS6866_7.5.0.0", "children": [] }, { "name": "Depression", "pageName": "ENAS6866_7.6.0.0", "children": [] }, { "name": "Disordered Eating Behavior", "pageName": "ENAS6866_7.7.0.0", "children": [] }, { "name": "Serious Mental Illness", "pageName": "ENAS6866_7.8.0.0", "children": [] }, { "name": "Cognitive Capacity\/Impairment", "pageName": "ENAS6866_7.10.0.0", "children": [] }, { "name": "Sleep Health", "pageName": "ENAS6866_7.11.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6866_8.0.0.0", "children": [] } ], "toolList": [], "videoList": [ { "id": "video_icon_4", "name": "DSMES Referral Form", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/erp-sample-physician-referral-form.pdf" } } }, { "id": "video_icon_5", "name": "Patient DSMES Benefits", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/dces_and_dsmes_promotional_flyer.pdf" } } }, { "id": "video_icon_6", "name": "Patient TX Intensification", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada_providerguide_final-2021-03-17.pdf" } } }, { "id": "video_icon_7", "name": "Patient Engagement Toolkit", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://therapeuticinertia.diabetes.org/patient-engagement-toolkit" } } }, { "id": "video_icon_8", "name": "Diabetes & Emotional Health Workbook", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/meetings/mentalhealthworkbook" } } }, { "id": "video_icon_9", "name": "Patient Behavior Assessment", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada_mental_health_toolkit_questionnaires.pdf" } } }, { "id": "video_icon_10", "name": "Patient Handouts", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada_mental_health_toolkit_handouts_r3.pdf" } } }, { "id": "video_icon_11", "name": "Mental Health Provider Directory", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/mhp_listing" } } }, { "id": "video_icon_12", "name": "Overcoming Barriers to Insulin", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/sites/professional.diabetes.org/files/media/ada_mental_health_workbook_appendix_d.pdf" } } }, { "id": "video_icon_13", "name": "Mental Health CE", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/meetings/mental-health-provider-diabetes-education-video-demand-program" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "video_icon_4", "video_icon_5", "video_icon_6", "video_icon_7", "video_icon_8", "video_icon_9", "video_icon_10", "video_icon_11", "video_icon_12", "video_icon_13" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#0092CB", "themeColor": "#0092CB", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Glycemic Targets", "cmsId": "ENAS6867", "guidelineId": "GL94", "positionOnHome": 9, "positionOnToc": 7, "tag": [], "abbrName": "Glycemic Targets", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6867_1.1.0.0", "children": [] }, { "name": "Assessment of Glycemic Control", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6867_2.1.0.0", "children": [] }, { "name": "Glycemic Assessment", "pageName": "ENAS6867_2.2.0.0", "children": [] }, { "name": "A1C Limitations", "pageName": "ENAS6867_2.3.0.0", "children": [] }, { "name": "Correlation Between BGM and A1C", "pageName": "ENAS6867_2.4.0.0", "children": [] }, { "name": "A1C Differences in Ethnic Populations and Children", "pageName": "ENAS6867_2.5.0.0", "children": [] }, { "name": "Glucose Assessment by Continuous Glucose Monitoring", "pageName": "ENAS6867_2.6.0.0", "children": [] } ] }, { "name": "Glycemic Goals", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6867_3.1.0.0", "children": [] }, { "name": "Recommednations", "pageName": "ENAS6867_3.2.0.0", "children": [] }, { "name": "A1C and Microvascular Complications", "pageName": "ENAS6867_3.3.0.0", "children": [] }, { "name": "A1C and Cardiovascular Disease Outcomes", "pageName": null, "children": [ { "name": "Cardiovascular Disease and Type 1 Diabetes", "pageName": "ENAS6867_3.4.1.0", "children": [] }, { "name": "Cardiovascular Disease and Type 2 Diabetes", "pageName": "ENAS6867_3.4.2.0", "children": [] } ] }, { "name": "Setting and Modifying A1C Goals", "pageName": "ENAS6867_3.5.0.0", "children": [] } ] }, { "name": "Hypoglycemia", "pageName": null, "children": [ { "name": "Recommednation", "pageName": "ENAS6867_4.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6867_4.2.0.0", "children": [] }, { "name": "Hypoglycemia Treatment", "pageName": "ENAS6867_4.3.0.0", "children": [] }, { "name": "Hypoglycemia Prevention", "pageName": "ENAS6867_4.4.0.0", "children": [] } ] }, { "name": "Intercurrent Illness", "pageName": "ENAS6867_5.0.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6867_6.0.0.0", "children": [] } ], "toolList": [ { "name": "A1C Target Individualization", "pageName": "interactive_0001690", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 6, "positionInHome": 1, "type": 1 } ], "videoList": [ { "id": "video_icon_17", "name": "TIR Resources", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/content-page/time-range" } } }, { "id": "video_icon_19", "name": "TIR CE", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professionaleducation.diabetes.org/Public/Catalog/Main.aspx" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0001690", "video_icon_15", "video_icon_17", "video_icon_19" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#1B81B9", "themeColor": "#1B81B9", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Diabetes Technology", "cmsId": "ENAS6868", "guidelineId": "GL95", "positionOnHome": 10, "positionOnToc": 8, "tag": [], "abbrName": "Diabetes Technology", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6868_1.0.0.0", "children": [] }, { "name": "General Device Principles", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6868_2.1.0.0", "children": [] }, { "name": "Education and Training", "pageName": "ENAS6868_2.2.0.0", "children": [] }, { "name": "Use in Schools", "pageName": "ENAS6868_2.3.0.0", "children": [] }, { "name": "Initiation of Device Use", "pageName": "ENAS6868_2.4.0.0", "children": [] } ] }, { "name": "Blood Glucose Monitoring", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6868_3.1.0.0", "children": [] }, { "name": "Meter Standards", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6868_3.2.1.0", "children": [] }, { "name": "Counterfeit Strips", "pageName": "ENAS6868_3.2.2.0", "children": [] } ] }, { "name": "Optimizing Blood Glucose Monitoring Device Use", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6868_3.3.1.0", "children": [] }, { "name": "People With Diabetes on Intensive Insulin Therapies", "pageName": "ENAS6868_3.3.2.0", "children": [] }, { "name": "People With Diabetes Using Basal Insulin and\/or Oral Agents and Noninsulin Injectables", "pageName": "ENAS6868_3.3.3.0", "children": [] }, { "name": "Glucose Meter Inaccuracy", "pageName": "ENAS6868_3.3.4.0", "children": [] } ] } ] }, { "name": "Continuous Glucose Monitoring Devices", "pageName": null, "children": [ { "name": "Recommendation", "pageName": "ENAS6868_4.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6868_2022120845", "children": [] }, { "name": "Benefits of Continuous Glucose Monitoring", "pageName": null, "children": [ { "name": "Data From Randomized Controlled Trials", "pageName": "ENAS6868_4.2.1.0", "children": [] }, { "name": "Observational and Real-World Studies", "pageName": "ENAS6868_4.2.2.0", "children": [] }, { "name": "Real-time Continuous Glucose Monitoring Compared With Intermittently Scanned Continuous Glucose Monitoring", "pageName": "ENAS6868_4.2.3.0", "children": [] }, { "name": "Data Analysis", "pageName": "ENAS6868_4.2.4.0", "children": [] }, { "name": "Real-time Continuous Glucose Monitoring Device Use in Pregnancy", "pageName": "ENAS6868_4.2.5.0", "children": [] }, { "name": "Use of Professional and Intermittent Continuous Glucose Monitoring", "pageName": "ENAS6868_4.2.6.0", "children": [] }, { "name": "Side Effects of Continuous Glucose Monitoring Devices", "pageName": "ENAS6868_4.2.7.0", "children": [] }, { "name": "Substances and Factors Affecting Continuous Glucose Monitoring Accuracy", "pageName": "ENAS6868_4.2.8.0", "children": [] } ] } ] }, { "name": "Insulin Delivery", "pageName": null, "children": [ { "name": "Insulin Syringes and Pens", "pageName": "ENAS6868_5.1.0.0", "children": [] }, { "name": "Insulin Pumps and Automated Insulin Delivery Systems", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6868_5.2.1.0", "children": [] }, { "name": "Insulin Pumps", "pageName": "ENAS6868_5.2.2.0", "children": [] }, { "name": "Insulin Pumps in Youth", "pageName": "ENAS6868_5.2.3.0", "children": [] }, { "name": "Sensor-Augmented Pumps", "pageName": "ENAS6868_5.2.4.0", "children": [] }, { "name": "Automated Insulin Delivery Systems", "pageName": "ENAS6868_5.2.5.0", "children": [] }, { "name": "Insulin Pumps in People With Type 2 and Other Types of Diabetes", "pageName": "ENAS6868_5.2.6.0", "children": [] } ] }, { "name": "Do-It-Yourself Closed-Loop Systems", "pageName": "ENAS6868_5.3.0.0", "children": [] }, { "name": "Digital Health Technology", "pageName": "ENAS6868_5.4.0.0", "children": [] }, { "name": "Inpatient Care", "pageName": "ENAS6868_5.5.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6868_6.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "video_icon_15", "video_icon_17", "video_icon_19" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#3670AA", "themeColor": "#3670AA", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes", "cmsId": "ENAS6869", "guidelineId": "GL96", "positionOnHome": 11, "positionOnToc": 9, "tag": [], "abbrName": "Obesity and Weight", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6869_1.1.0.0", "children": [] }, { "name": "Assessment", "pageName": "ENAS6869_2.0.0.0", "children": [] }, { "name": "Nutrition, Physical Activity, And Behavioral Therapy", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6869_3.1.0.0", "children": [] }, { "name": "Look AHEAD Trial", "pageName": "ENAS6869_3.2.0.0", "children": [] }, { "name": "Behavioral Interventions", "pageName": "ENAS6869_3.3.0.0", "children": [] } ] }, { "name": "Pharmacotherapy", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6869_4.1.0.0", "children": [] }, { "name": "Glucose-Lowering Therapy", "pageName": "ENAS6869_4.2.0.0", "children": [] }, { "name": "Concomitant Medications", "pageName": "ENAS6869_4.3.0.0", "children": [] }, { "name": "Approved Obesity Pharmacotherapy Options", "pageName": "ENAS6869_4.4.0.0", "children": [] }, { "name": "Assessing Efficacy and Safety", "pageName": "ENAS6869_4.5.0.0", "children": [] } ] }, { "name": "Medical Devices For Weight Loss", "pageName": "ENAS6869_5.0.0.0", "children": [] }, { "name": "Metabolic Surgery", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6869_6.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6869_6.2.0.0", "children": [] }, { "name": "Potential Risks and Complications", "pageName": "ENAS6869_6.3.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6869_7.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#515E9A", "themeColor": "#515E9A", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Pharmacologic Approaches to Glycemic Treatments", "cmsId": "ENAS6870", "guidelineId": "GL97", "positionOnHome": 12, "positionOnToc": 10, "tag": [], "abbrName": "Pharmacologic Approaches", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6870_1.1.0.0", "children": [] }, { "name": "Pharmacologic Therapy for Adults with Type 1 Diabetes", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6870_2.1.0.0", "children": [] }, { "name": "Insulin Therapy", "pageName": "ENAS6870_2.2.0.0", "children": [] }, { "name": "Insulin Injection Technique", "pageName": "ENAS6870_2.3.0.0", "children": [] }, { "name": "Noninsulin Treatments for Type 1 Diabetes", "pageName": "ENAS6870_2.4.0.0", "children": [] } ] }, { "name": "Pharmacologic Therapy for Adults with Type 2 Diabetes", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6870_3.1.0.0", "children": [] }, { "name": "Overview", "pageName": "ENAS6870_3.2.0.0", "children": [] }, { "name": "Choice of Glucose-Lowering Therapy", "pageName": "ENAS6870_3.3.0.0", "children": [] }, { "name": "Combination Therapy", "pageName": "ENAS6870_3.4.0.0", "children": [] }, { "name": "Cardiovascular Outcomes Trials", "pageName": "ENAS6870_3.5.0.0", "children": [] }, { "name": "Insulin Therapy", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6870_3.6.1.0", "children": [] }, { "name": "Basal Insulin", "pageName": "ENAS6870_3.6.2.0", "children": [] }, { "name": "Prandial Insulin", "pageName": "ENAS6870_3.6.3.0", "children": [] }, { "name": "Concentrated Insulins", "pageName": "ENAS6870_3.6.4.0", "children": [] }, { "name": "Alternative Insulin Routes", "pageName": "ENAS6870_3.6.5.0", "children": [] } ] }, { "name": "Combination Injectable Therapy", "pageName": "ENAS6870_3.7.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6870_4.0.0.0", "children": [] } ], "toolList": [ { "name": "Medications for Lowering Glucose, Summary of Characteristics", "pageName": "interactive_0001693", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_3", "positionInToc": 2, "positionInHome": 1, "type": 1 }, { "name": "Use of Glucose-Lowering Medications in The Management of Type 2 Diabetes", "pageName": "interactive_0003780", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_1", "positionInToc": 3, "positionInHome": 2, "type": 2 }, { "name": "Intensifying to Injectable Therapies in Type 2 Diabetes", "pageName": "interactive_0002036", "hasPdf": true, "isBlocked": false, "isDeleted": false, "iconName": "tool_2", "positionInToc": 4, "positionInHome": 3, "type": 2 } ], "videoList": [ { "id": "video_icon_15", "name": "Consumer Guide", "defaultProperties": { "color": { "backgroundColor": "#C31230", "themeColor": "#C31230", "textColor": "#FFFFFF" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://consumerguide.diabetes.org/" } } } ], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [ "interactive_0001693", "interactive_0003780", "interactive_0002036", "video_icon_6", "video_icon_15", "video_icon_13" ], "subGuideline": [], "colorInfo": { "backgroundColor": "#6C4D8B", "themeColor": "#6C4D8B", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "General Information", "cmsId": "ENAS6862", "guidelineId": "GL88", "positionOnHome": 3, "positionOnToc": 1, "tag": [], "abbrName": "General Information", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Introduction and Methodology: Standards of Care in Diabetes\u20142023", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6862_1.1.0.0", "children": [] }, { "name": "Target Audience", "pageName": "ENAS6862_1.2.0.0", "children": [] }, { "name": "Methodology and Procedure", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6862_1.3.1.0", "children": [] }, { "name": "Professional Practice Committee", "pageName": "ENAS6862_1.3.2.0", "children": [] }, { "name": "Disclosure and Duality of Interest Management", "pageName": "ENAS6862_1.3.3.0", "children": [] }, { "name": "Evidence Review", "pageName": "ENAS6862_1.3.4.0", "children": [] }, { "name": "Grading of Evidence and Recommendation Development", "pageName": "ENAS6862_1.3.5.0", "children": [] }, { "name": "Revision Process", "pageName": "ENAS6862_1.3.6.0", "children": [] } ] }, { "name": "ADA Standards, Statements, Reports, and Reviews", "pageName": "ENAS6862_1.4.0.0", "children": [] }, { "name": "Acknowledgments", "pageName": "ENAS6862_1.5.0.0", "children": [] }, { "name": "References", "pageName": "ENAS6862_1.6.0.0", "children": [] } ] }, { "name": "Summary of Revisions: Standards of Care in Diabetes\u20142023", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6862_2.1.0.0", "children": [] }, { "name": "General Changes", "pageName": "ENAS6862_2.2.0.0", "children": [] }, { "name": "Section Changes", "pageName": null, "children": [ { "name": "Section 1. Improving Care and Promoting Health in Populations", "pageName": "ENAS6862_2.3.1.0", "children": [] }, { "name": "Section 2. Classification and Diagnosis of Diabetes", "pageName": "ENAS6862_2.3.2.0", "children": [] }, { "name": "Section 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities", "pageName": "ENAS6862_2.3.3.0", "children": [] }, { "name": "Section 4. Comprehensive Medical Evaluation and Assessment of Comorbidities", "pageName": "ENAS6862_2.3.4.0", "children": [] }, { "name": "Section 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes", "pageName": "ENAS6862_2.3.5.0", "children": [] }, { "name": "Section 6. Glycemic Targets", "pageName": "ENAS6862_2.3.6.0", "children": [] }, { "name": "Section 7. Diabetes Technology", "pageName": "ENAS6862_2.3.7.0", "children": [] }, { "name": "Section 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes", "pageName": "ENAS6862_2.3.8.0", "children": [] }, { "name": "Section 9. Pharmacologic Approaches to Glycemic Treatment", "pageName": "ENAS6862_2.3.9.0", "children": [] }, { "name": "Section 10. Cardiovascular Disease and Risk Management", "pageName": "ENAS6862_2.3.10.0", "children": [] }, { "name": "Section 11. Chronic Kidney Disease and Risk Management", "pageName": "ENAS6862_2.3.11.0", "children": [] }, { "name": "Section 12. Retinopathy, Neuropathy, and Foot Care", "pageName": "ENAS6862_2.3.12.0", "children": [] }, { "name": "Section 13. Older Adults", "pageName": "ENAS6862_2.3.13.0", "children": [] }, { "name": "Section 14. Children and Adolescents", "pageName": "ENAS6862_2.3.14.0", "children": [] }, { "name": "Section 15. Management of Diabetes in Pregnancy", "pageName": "ENAS6862_2.3.15.0", "children": [] }, { "name": "Section 16. Diabetes Care in the Hospital", "pageName": "ENAS6862_2.3.16.0", "children": [] }, { "name": "Section 17. Diabetes Advocacy", "pageName": "ENAS6862_2.3.17.0", "children": [] } ] } ] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "textColor": "#000000", "backgroundColor": "#0000ff", "themeColor": "#313284" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "SoC Tools", "cmsId": "ENAS2222", "guidelineId": "GL500", "positionOnHome": 2, "positionOnToc": -1, "tag": [], "abbrName": "SOC Tools", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Overview", "pageName": "ENAS6861_1.0.0.0", "children": [] }, { "name": "Diabetes and Population Health", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_2.1.0.0", "children": [] }, { "name": "Care Delivery Systems", "pageName": null, "children": [ { "name": "Overview", "pageName": "ENAS6861_2.2.1.0", "children": [] }, { "name": "Chronic Care Model", "pageName": "ENAS6861_2.2.2.0", "children": [] }, { "name": "Strategies for System-Level Improvement", "pageName": "ENAS6861_2.2.3.0", "children": [] }, { "name": "Care Teams", "pageName": "ENAS6861_2.2.4.0", "children": [] }, { "name": "Telehealth", "pageName": "ENAS6861_2.2.5.0", "children": [] }, { "name": "Behaviors and Well-being", "pageName": "ENAS6861_2.2.6.0", "children": [] }, { "name": "Cost Considerations for Medication-Taking Behaviors", "pageName": "ENAS6861_2.2.7.0", "children": [] }, { "name": "Access to Care and Quality Improvement", "pageName": "ENAS6861_2.2.8.0", "children": [] } ] } ] }, { "name": "Tailoring Treatment for Social Context", "pageName": null, "children": [ { "name": "Recommendations", "pageName": "ENAS6861_3.1.0.0", "children": [] }, { "name": "Food Insecurity", "pageName": "ENAS6861_3.2.0.0", "children": [] }, { "name": "Homelessness and Housing Insecurity", "pageName": "ENAS6861_3.3.0.0", "children": [] }, { "name": "Migrant and Seasonal Agricultural Workers", "pageName": "ENAS6861_3.4.0.0", "children": [] }, { "name": "Language Barriers", "pageName": "ENAS6861_3.5.0.0", "children": [] }, { "name": "Health Literacy and Numeracy", "pageName": "ENAS6861_3.6.0.0", "children": [] }, { "name": "Social Capital\/Community Support", "pageName": "ENAS6861_3.7.0.0", "children": [] } ] }, { "name": "References", "pageName": "ENAS6861_4.0.0.0", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "backgroundColor": "#274592", "themeColor": "#313284", "textColor": "#FFFFFF" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1665489288" }, { "name": "Shell Guideline", "cmsId": "ENAS6682", "guidelineId": "GL1001", "positionOnHome": 1, "positionOnToc": -1, "tag": [], "abbrName": "", "author": "", "sponsors": [ "" ], "publishedYear": "", "children": [ { "name": "Shell Guideline", "pageName": "ENAS6682_202209021", "children": [] } ], "toolList": [], "videoList": [], "congressList": [], "firstChapterOnTablet": "", "extraIconsList": [ { "id": "external_icon_1", "name": "eAG/A1C Conversion", "defaultProperties": { "color": { "backgroundColor": "#FEF8F4", "themeColor": "#FEF8F4", "textColor": "#C31230" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/diapro/glucose_calc" } } }, { "id": "external_icon_2", "name": "Podcasts", "defaultProperties": { "color": { "backgroundColor": "#FEF8F4", "themeColor": "#FEF8F4", "textColor": "#C31230" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/landing/podcast" } } }, { "id": "external_icon_3", "name": "COVID-19 Hub Pre-vaccine", "defaultProperties": { "color": { "backgroundColor": "#FEF8F4", "themeColor": "#FEF8F4", "textColor": "#C31230" }, "enabled": true, "onClick": { "target": "2", "parameter": "https://professional.diabetes.org/content-page/covid-19" } } }, { "id": "external_icon_4", "name": "Education Recognition Program (ERP) Listing Finder", "defaultProperties": { "color": { "backgroundColor": "#FEF8F4", "themeColor": "#FEF8F4", "textColor": "#C31230" }, "enabled": true, "onClick": { "target": "8", "parameter": "ExtraIcons/GL101/ERP_locator.html" } } }, { "id": "external_icon_5", "name": "Mental Health", "defaultProperties": { "color": { "backgroundColor": "#FEF8F4", "themeColor": "#FEF8F4", "textColor": "#C31230" }, "enabled": true, "onClick": { "target": "8", "parameter": "ExtraIcons/GL101/Mental_health.html" } } } ], "pdfList": [], "landingPageSequence": [], "subGuideline": [], "colorInfo": { "textColor": "#000000", "backgroundColor": "#0000ff", "themeColor": "#a29060" }, "splash": { "extra1": "", "extra2": "" }, "guidelineVersion": "v1.0", "timestamp": "1669809083" } ]